0
Skip to Content
Avalyra
Home
Team
Investors
Avalyra
Home
Team
Investors
Home
Team
Investors

Disclaimer: The Avalyra Biophotonic devices are currently under development and have not been reviewed or approved by the U.S. Food and Drug Administration (FDA). All references to intended use, performance, and benefits reflect the company’s goals and anticipated outcomes pending successful clinical validation and regulatory clearance. This product is not yet available for sale.

EST. 2024
Chicago, IL | Syracuse, NY | Washington, D.C.
SAM.gov: Active  |  CAGE Code: 11S60 |  NAICS Codes: 334510, 541714, 541715

Contact Us

© AVALYRA, INC.  2025